Predictive Model of Risk Factors for the Recurrence of Liver Cirrhosis with Pleural Effusion

Min ZHOU; Zhihui MA; Jiayan LI; Jianhua FAN; Ling LIN; Tingying YU; Huifang ZHANG; Li LIU

doi:10.12259/j.issn.2095-610X.S20220524

Volume 43 Issue 5

May 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(5): 149-154

Min ZHOU, Zhihui MA, Jiayan LI, Jianhua FAN, Ling LIN, Tingying YU, Huifang ZHANG, Li LIU. Predictive Model of Risk Factors for the Recurrence of Liver Cirrhosis with Pleural Effusion[J]. Journal of Kunming Medical University, 2022, 43(5): 149-154. doi: 10.12259/j.issn.2095-610X.S20220524

Citation:

Min ZHOU, Zhihui MA, Jiayan LI, Jianhua FAN, Ling LIN, Tingying YU, Huifang ZHANG, Li LIU. Predictive Model of Risk Factors for the Recurrence of Liver Cirrhosis with Pleural Effusion[J]. Journal of Kunming Medical University, 2022, 43(5): 149-154. doi: 10.12259/j.issn.2095-610X.S20220524

Citation:

Min ZHOU, Zhihui MA, Jiayan LI, Jianhua FAN, Ling LIN, Tingying YU, Huifang ZHANG, Li LIU. Predictive Model of Risk Factors for the Recurrence of Liver Cirrhosis with Pleural Effusion[J]. Journal of Kunming Medical University, 2022, 43(5): 149-154. doi: 10.12259/j.issn.2095-610X.S20220524

PDF( 1056 KB)

Predictive Model of Risk Factors for the Recurrence of Liver Cirrhosis with Pleural Effusion

doi: 10.12259/j.issn.2095-610X.S20220524

Dept.of Liver Disease，The 3rd People’s Hospital of Kunming City/Yunnan Infectious Disease Clinical Medical Center，Kunming Yunnan 650041，China

Received Date: 2022-01-04
Publish Date: 2022-05-25

Abstract

Abstract

Objective To explore the independent risk factors of the recurrence of pleural effusion in patients with liver cirrhosis and complicated with pleural effusion and to establish a predictive model. Methods 190 cases of liver cirrhosis complicated with massive pleural effusion and admitted to the department of infectious diseases from April 2014 to December 2019 were inquired. The recurrence of pleural effusion after the treatment was followed up, and the relevant clinical data and laboratory indexes were collected. The patients were divided into non pleural effusion recurrence group （n = 161） and pleural effusion recurrence group （n = 29） and ROC curve was used to verify the prediction efficiency of the prediction model. Results Among the 190 patients, 29 （15%） recurred after the disappearance of pleural effusion after the treatment. The factors such as baseline age, gender, blood routine and liver function of 190 patients were analyzed by logistic regression. Platelet （or = 1.018）, blood creatinine （or = 0.978）, portal vein velocity （or = 0.660） and catheterization time （or = 1.801） were independent risk factors for the recurrence of pleural effusion in patients with liver cirrhosis. The AUC of the four risk factors and the model were 0.673, 0.619, 0.831, 0.969 and 0.977 respectively. The sensitivity, specificity and accuracy of the model were 89.7%, 92.9% and 91.8% respectively. Conclusion The prediction model of pleural effusion recurrence in patients with liver cirrhosis and combined with pleural effusion could better predict the risk of pleural effusion recurrence.Early intervention of influencing factors could reduce the recurrence of pleural effusion in patients with liver cirrhosis, and provide the reference for medical staff to take the preventive management measures in time.
- Liver cirrhosis,
- Recurrence of pleural effusion,
- Risk factors,
- Prediction model

FullText(HTML)

References(14)

References

[1]	Gilbert C R,Shojaee S,Maldonado F,et al. Pleural interventions in the management of hepatic hydrothorax[J]. Chest,2022,161(1):276-283. doi: 10.1016/j.chest.2021.08.043
[2]	Yoon J H,Kim H J,Jun C H,et al. Various treatment modalities in hepatic hydrothorax:What is safe and effective?[J]. Yonsei Med J,2019,60(10):944-951. doi: 10.3349/ymj.2019.60.10.944
[3]	陈盛鹏,傅世祥,李敏,等. 体位改变辅助治疗右侧肝性胸水1例[J]. 肝脏,2020,25(6):657. doi: 10.3969/j.issn.1008-1704.2020.06.037
[4]	Mouelhi L,Daboussi O,Cheffi N,et al. Hepatic hydrothorax:About a hospital serie of 63 cases.[J]. Tunis Med,2016,94(12):867.
[5]	聂深钰,时宇,高普均. 难治性肝性胸水的治疗[J]. 中国老年学杂志,2015,35(11):3171-3173. doi: 10.3969/j.issn.1005-9202.2015.11.142
[6]	中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志,2019,35(11):2408-2425. doi: 10.3969/j.issn.1001-5256.2019.11.006
[7]	田莉婷,傅琪琳,李兴国,等. 麻芪桂术汤配合西药治疗阳虚水停型肝性胸水临床观察[J]. 陕西中医,2016,37(7):860-861. doi: 10.3969/j.issn.1000-7369.2016.07.048
[8]	叶珣. 漏出性胸腔积液46例临床病因及分析[J]. 中国保健营养,2018,28(17):273. doi: 10.3969/j.issn.1004-7484.2018.17.361
[9]	马陈斌. 肝硬化腹水的临床治疗应用效果观察[J]. 世界最新医学信息文摘(连续型电子期刊),2019,19(27):72-83.
[10]	Kamath P S,Wiesner R H,Malinchoc M,et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology,2001,33(2):464-470. doi: 10.1053/jhep.2001.22172
[11]	林殿杰,孙洪军,黄琛,等. 胸腔镜对肝性胸水病人的诊断和治疗价值[J]. 中华肝脏病杂志,2002,10(6):462. doi: 10.3760/j.issn:1007-3418.2002.06.022
[12]	李海军,郭志梅,杨新英,等. 不同频次胸腔穿刺抽液及置管引流对肝硬化失代偿期合并顽固性胸水患者的影响[J]. 国际流行病学传染病学杂志,2017,44(2):85-89. doi: 10.3760/cma.j.issn.1673-4149.2017.02.003
[13]	楼良潮,陆文博. 食管癌伴肝硬化的手术治疗[J]. 中国实用医刊,2015,42(12):75-76. doi: 10.3760/cma.j.issn.1674-4756.2015.12.034
[14]	张骏,孙文兵. 肝性胸水[J]. 中国临床医生,2013,41(8):558-559.

Relative Articles(20)

Relative Articles

[1]	Lu ZHANG, Ye LI, Qingqing WANG, Shenghao LI. Advances in Research on the Effects of Liver Cirrhosis on Cardiovascular System and Related Mechanisms. Journal of Kunming Medical University, 2024, 45(6): 1-6. doi: 10.12259/j.issn.2095-610X.S20240601
[2]	Huijuan ZENG, Bo TIAN, Hongling YUAN, Jie HE, Guanxi LI, Guojia RU, Min XU, Dong ZHAN. Predictive Modeling of Chronic Kidney Disease with Hypertension or Diabetes Based on Machine Learning Algorithms. Journal of Kunming Medical University, 2024, 45(3): 99-105. doi: 10.12259/j.issn.2095-610X.S20240315
[3]	Yanmei JI, Wenjun LI, Qingyun LI, Ni GUO, Ni MENG, Dan ZHOU, Qiuyu LI, Xingfang JIN. The Analysis of Related Factors of Cognitive Impairment after the Acute Ischemic Stroke and Construction of Nomogram Model. Journal of Kunming Medical University, 2024, 45(5): 73-81. doi: 10.12259/j.issn.2095-610X.S20240511
[4]	Kang HUANG, Zhirong ZHAO, Haiwen LI, Ti WU, Ting JIA, Lu WANG, Nihong LU, Yongrui YANG. Efficacy and Safety of Sofosbuvir/Velpatasvir with or without Ribavirin in Cirrhotic Patients with Genotype 3 Chronic Hepatitis C Infection. Journal of Kunming Medical University, 2023, 44(11): 126-134. doi: 10.12259/j.issn.2095-610X.S20231119
[5]	Jingyu YANG, Ning XU, Yutao ZHANG, Fengchang HUANG, Yuanming JIANG, Liang YIN. Comparative Study of Multiple Models Based on Baseline T2WI Images for Predicting Pathological Complete Remission of Progressive Rectal Cancer after Neo-adjuvant Chemoradiotherapy. Journal of Kunming Medical University, 2023, 44(5): 117-124. doi: 10.12259/j.issn.2095-610X.S20230512
[6]	Peizheng XIANG, Mengli LI, Yan FU. Value of Multiple Scoring Systems in Evaluating the Prognosis of Liver Cirrhosis Complicated with Esophageal and Gastric Varices Bleeding. Journal of Kunming Medical University, 2022, 43(3): 128-134. doi: 10.12259/j.issn.2095-610X.S20220316
[7]	Siqi LI, Wenlin TAI. Significance of CXCL10 as a Biomarker of Liver Cirrhosis. Journal of Kunming Medical University, 2022, 43(7): 55-61. doi: 10.12259/j.issn.2095-610X.S20220711
[8]	Qingqing WANG, Jie DING, Hongjie YANG, Guoji CHANG, Siqi LIU, Lijuan HUA, Yiying WANG, Shenghao LI. Predictive Value of RDW and Blood Lipid on Gastroesophageal Variceal Bleeding in Patients with Liver Cirrhosis. Journal of Kunming Medical University, 2022, 43(5): 144-148. doi: 10.12259/j.issn.2095-610X.S20220509
[9]	Ji JIA, Siming TAO. Development of A Plasma Osmolality Prediction Model for the Risk of In-hospital Death in Critically Ill Patients with Acute ST-segment Elevation Myocardial Infarction. Journal of Kunming Medical University, 2022, 43(12): 58-65. doi: 10.12259/j.issn.2095-610X.S20221212
[10]	Hong WANG, Dexing YANG, Qiang WANG, Weiyu ZHOU, Jiefu TANG, Zhenfang WANG, Kai FU, Shengzhe LIU, Rong LIU. Risk Factors Analysis and Prediction Model Establishment of Refeeding Syndrome in ICU Patients with Sepsis. Journal of Kunming Medical University, 2022, 43(11): 44-51. doi: 10.12259/j.issn.2095-610X.S20221102
[11]	Guimei ZHANG, Shu CHEN, Yunhua SONG, Yang WU, Hongyuan ZHOU. Risk Factors of Readmission in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Establishment of Risk Prediction Model. Journal of Kunming Medical University, 2022, 43(8): 184-190. doi: 10.12259/j.issn.2095-610X.S20220830
[12]	Xing LIU, Yuan LIU, Xiang-fang LIU, Jie CHEN, Yong-gang CHEN, Hui SUN, Ling MA. Adverse Reactions Analysis and Prediction Model of Cefoperazone Sodium Sulbactam Sodium. Journal of Kunming Medical University, 2021, 42(6): 139-145. doi: 10.12259/j.issn.2095-610X.S20210622
[13]	Jing-rong DAI, Jie LI, Xu HE, Yang LI, Yan LI. Risk Factors Analysis and Risk Prediction Model Construction of Depression in Inpatients of Geriatrics Department of a Hospital in Yunnan. Journal of Kunming Medical University, 2021, 42(11): 20-26. doi: 10.12259/j.issn.2095-610X.S20211104
[14]	Jiang Ming Yuan , Huang Hua , Lu Ming Liang , Ding Wen Jing , Wang Jia Ping , Zheng Su Yun , Shi Xin . . Journal of Kunming Medical University, 2020, 41(02): 32-36.
[15]	Ji Hong . . Journal of Kunming Medical University,
[16]	Zhang Ying Ying . . Journal of Kunming Medical University,
[17]	Yang Yong Rui . . Journal of Kunming Medical University,
[18]	Li Wei Hua . . Journal of Kunming Medical University,
[19]	Wang Yun . . Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,